김유천 (KAIST)님 | 한빛사연구자 > 한빛사

KAIST

CV File

최종업데이트 2021.02.04.

Local delivery of IL-12 mRNA and indoximod prodrug potentiates antitumor immunity by increasing T cell effector function
- J. Control. Release, Jun 18 2025, S0168-3659(25)00591-7 | https://doi.org/10.1016/j.jconrel.2025.113970
- 2025-06
- 바이오·의료융합
- 한빛사논문
Metal-phenolic networks reverse the immunosuppressive tumor microenvironment via dual metabolism regulation and immunogenic cell death
- J. Control. Release, Apr 26 2025, S0168-3659(25)00395-5 | https://doi.org/10.1016/j.jconrel.2025.113775
- 2025-04
- 한빛사논문
Cell membrane nanoparticles in cancer therapy: From basic structure to surface functionalization
- J. Control. Release, Apr 18 2025, S0168-3659(25)00372-4 | https://doi.org/10.1016/j.jconrel.2025.113752
- 2025-04
- 바이오·의료융합
- 한빛사논문
Tumor phagocytosis-driven STING activation invigorates antitumor immunity and reprograms the tumor micro-environment
- J. Control. Release, Jul 04 2024, S0168-3659(24)00435-8 | https://doi.org/10.1016/j.jconrel.2024.07.004
- 2024-07
- 생명과학
- 한빛사논문
Enhanced Photodynamic Cancer Treatment by Mitochondria-Targeting and Brominated Near-Infrared Fluorophores
- Adv. Sci., Volume5, Issue3 March 2018 1700481 | https://doi.org/10.1002/advs.201700481
- 2018-03
- 바이오·의료융합
- 상위피인용논문
Immunogenic Cell Death Inducing Fluorinated Mitochondria‐Disrupting Helical Polypeptide Synergizes with PD‐L1 Immune Checkpoint Blockade
- Adv. Sci., First published: 01 February 2021 | https://doi.org/10.1002/advs.202001308
- 2021-02
- 생명과학
- 한빛사논문
A Helical Polypeptide‐Based Potassium Ionophore Induces Endoplasmic Reticulum Stress‐Mediated Apoptosis by Perturbing Ion Homeostasis
- Adv. Sci., First published: 24 May 2019 | https://doi.org/10.1002/advs.201801995
- 2019-05
- 바이오·의료융합
- 한빛사논문
- 김유천(KAIST,이화여자대학교,한국생명공학연구원)
Microneedles for drug and vaccine delivery
- Adv. Drug Deliv. Rev., Volume 64, Issue 14, November 2012, Pages 1547–1568. | http://dx.doi.org/10.1016/j.addr.2012.04.005
- 2012-05
- 한빛사논문, 상위피인용논문

연구자 ID

저자논문

저자논문

저자논문

저자논문

CV 열람하기

연락처 보기